Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2023）
摘要
Immunosuppressive treatment more than disease type per se is a risk factor for a low humoral response after vaccination. The booster dose can improve both humoral and T-cell responses.
更多查看译文
关键词
Fragile patients,SARS-CoV-2 mRNA vaccine,T-cell immunity,humoral immunity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要